Risultati della ricerca

• 21. CV Hypatia C. Corrado (20%)

  25-giu-2013 10.13.38

  EC, DE LEO G (2008). Effects of carboxyamidotriazole on in vitro models of imatinib-resistant

• 22. Program Summer School Palermo 2014 (20%)

  6-ago-2014 16.13.58

  to bridge in vivo / in application for gene therapy” vitro models, vascular bioprosthesis and

• 23. Esami finali di Dottorato Internazionale in “Oncologia e Chirurgia Sperimentali” Ciclo XXX (20%)

  2-mag-2018 13.55.39

  (NSCLC) Pucci Marzia: Exosome analysis in Non Small Cell Lung Cancer: from in vitro models

• 24. GA_Baccarella_Marta (20%)

  10-giu-2024 17.48.57

  Bio-fabrication methods and computational approaches applied to cardiovascular tissue engineering scaffolds and in-vitro models Marta Baccarella Cardiovascular tissue engineering marta.baccarella@unipa.it Concept: In 2020, 19 million deaths were attributed to CLINICAL NEED cardiovascular diseases (CVDs), including stroke, and atherosclerosis [1]. Blood-contacting devices play a pivotal role in managing CVDs since one of the most common causes of their failure is the formation of blood clots

• 25. Progetti Dottorato di ricerca XXX ciclo (concluso) (20%)

  11-nov-2021 8.59.32

  Tesi di dottorato Exosome analysis in Non Small Cell Lung Cancer: from in vitro models

• 26. Ciclo XXXVIII (38) (20%)

  28-mar-2025 11.25.11

  to cardiovascular tissue engineering scaffolds and in-vitro models Tutor: Vincenzo La Carrubba

• 27. oncologia e chirurgia sperimentali (17%)

  25-lug-2017 12.19.00

  -dipendenti. - Studies on drug absorption from the oral cavity: Researches by ex vivo and in vitro models represent the fundamental scientific rationale for the development of new pharmaceutical

• 28. ASSEGNO DI RICERCA (17%)

  9-ott-2020 12.19.37

  neoplastic diseases, the extracts will be tested on in vitro models of hepatocarcinoma and

• 29. pa_art24c6_bio10_verbale 2_protetto (17%)

  25-gen-2022 13.47.29

  del capitolo 9 "In vitro models of blood-brain barrier formation and functioning", del libro

• 30. Attività formative ciclo XXXVIII (17%)

  6-giu-2023 17.13.18

  Giuliano will introduce the main in vitro models for preclinical experimentation. In particular, the main

• 31. CV_FONTANA_marzo 2022 (17%)

  17-mar-2022 10.03.04

• 32. Attività formative ciclo XXXIX (17%)

  11-lug-2023 15.25.32

  years. Subsequently, Prof. Michela Giuliano will introduce the main in vitro models for preclinical

• 33. progettazione dottorato TSSU_V-39 (17%)

  11-lug-2023 15.43.14

  implemented in recent years. Subsequently, Prof. Michela Giuliano will introduce the main in vitro models for preclinical experimentation. In particular, the main types of cell cultures, including

• 34. 30 bandi 2020 (17%)

  3-giu-2020 14.32.09

  by an inflammatory component including neoplastic diseases, the extracts will be tested on in vitro models

• 35. 30 english version bando_2020 (17%)

  3-giu-2020 14.32.09

  including neoplastic diseases, the extracts will be tested on in vitro models

• 36. 67 bando 2020 (17%)

  6-ott-2020 13.34.18

  neoplastic diseases, the extracts will be tested on in vitro models of hepatocarcinoma and

• 37. 67 english version bando 2020 (17%)

  6-ott-2020 13.34.19

  diseases, the extracts will be tested on in vitro models of hepatocarcinoma and

• 38. 19 bando (17%)

  18-lug-2019 12.24.59

  will be tested on in vitro models of hepatocarcinoma and on endothelial cell models to verify their ability

• 39. progettazione dottorato TSSU40 (17%)

  1-lug-2024 14.31.57

  . Subsequently, Prof. Michela Giuliano will introduce the main in vitro models for preclinical

• 40. AIR² - July 2017 - Issue n°19 (17%)

  13-lug-2017 11.47.22

  innovative in vitro models and analytical algae, plants, invertebrates (e.g. the waterflea